France Approves AstraZeneca COVID Vaccine for Use

The health minister of France announced on Monday that the government allowed expanding the use of AstraZeneca’s COVID-19 vaccine after new clinical results proved its effectiveness among individuals aged over 65.

In a press release, French health minister Olivier Véran said that the government decided to depart from its earlier stance and opted to allow people aged over 65 with pre-existing health conditions – like high blood pressure or diabetes – to get a shot of the Oxford/AstraZeneca Covid-19 vaccine.

“The Haute Autorité de Santé now considers as of today that all three vaccines that we have in France have a remarkable efficacy to protect people against the risk of severe forms of Covid-19,” Véran said during the interview.

“As a result, I can announce that from now on people aged 50 and above who have comorbidities such as diabetes, high blood pressure or a history of cancer can be vaccinated with AstraZeneca, including those aged 65 to 74.”

In February, the French government restricted the use of vaccine for individuals aged under-65s only, citing the vaccine’s lack of sufficient data for the elderly.

Véran added that people aged over 75 would still be offered vaccines from either Pfizer or Moderna only.

© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.